Roivant Sciences Ltd. — Director's Dealing 2022

Nov 15, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2022-11-09

Reporting Person: MANCHESTER KEITH S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-11-09	Common Shares	J	1196200	—	Disposed	38582314	Indirect
2022-11-10	Common Shares	S	1092355	$4.75	Disposed	37489959	Indirect
2022-11-10	Common Shares	S	372427	$4.75	Disposed	13535929	Indirect
2022-11-10	Common Shares	S	2311643	$4.75	Disposed	28010344	Indirect
2022-11-10	Common Shares	S	146079	$4.75	Disposed	5470181	Indirect

Footnotes

F1: Shares were distributed in-kind to certain shareholders of QVT Financial Investment Cayman Ltd. who subsequently gifted the shares to charitable foundations, each of which is subject to a lock-up.

F2: The reporting person is a shareholder of each of QVT Roiv Hldgs Onshore Ltd., QVT Deferred Compensation Holdings Ltd., QVT P&E Roiv Hldgs Ltd. and QVT Financial Investment Cayman Ltd. (the "QVT Entities") but does not have any voting or investment control over the QVT Entities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.